Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | Glucotrack, Inc.: Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting | 1 | GlobeNewswire (USA) | ||
24.07. | Glucotrack, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
08.07. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
08.07. | Glucotrack, Inc.: Glucotrack Announces Repurchase of Series A Warrants | 1 | GlobeNewswire (USA) | ||
27.06. | Pre-market Movers: Blue Gold, INmune Bio, Cyngn, NanoVibronix, GlucoTrack | 738 | AFX News | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.20 A.M. ET).In the Green Blue Gold Limited (BGL) is up over 297% at $80.01.
INmune... ► Artikel lesen | |
25.06. | GlucoTrack Stock Jumps 40% On Strong Clinical Data For Implantable Glucose Monitor | 2 | RTTNews | ||
25.06. | Why Is This Nano-Cap Glucotrack Stock Trading Higher On Wednesday? | 3 | Benzinga.com | ||
GLUCOTRACK Aktie jetzt für 0€ handeln | |||||
25.06. | Glucotrack reports positive results from first human trial of blood glucose monitor | 3 | Investing.com | ||
25.06. | Glucotrack berichtet über positive Ergebnisse der ersten klinischen Studie am Menschen | 2 | Investing.com Deutsch | ||
25.06. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
23.06. | A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology | 1 | MassDevice | ||
12.06. | Glucotrack announces 1-for-60 reverse stock split effective June 16 | 2 | Investing.com | ||
12.06. | Glucotrack, Inc. - 8-K, Current Report | - | SEC Filings | ||
12.06. | GlucoTrack, Inc.: Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements | 251 | GlobeNewswire (Europe) | 1-for-60 reverse stock split to become effective as of the opening of trading on June 16, 2025 Rutherford, NJ, June 12, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the... ► Artikel lesen | |
04.06. | Glucotrack, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
04.06. | Glucotrack, Inc.: Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions | 1 | GlobeNewswire (USA) | ||
28.05. | Glucotrack appoints new board member with diabetes tech expertise | 1 | Investing.com | ||
28.05. | Glucotrack, Inc.: Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD | 14 | GlobeNewswire (USA) | ||
20.05. | Glucotrack, Inc.: Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development | 1 | GlobeNewswire (USA) | ||
20.05. | Glucotrack, Inc. - 8-K, Current Report | - | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ECKERT & ZIEGLER | 62,28 | +0,77 % | Eckert & Ziegler: Aktiensplit nach Kapitalerhöhung eingetragen | Eckert & Ziegler hat die im Juni beschlossene Kapitalerhöhung aus Gesellschaftsmitteln vollzogen. Das Grundkapital des Unternehmens wurde um 42,3 Millionen Euro auf 63,5 Millionen Euro erhöht. Die Eintragung... ► Artikel lesen | |
SERNOVA BIOTHERAPEUTICS | 0,115 | -4,96 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Studienergebnisse zeigen: Darmmikrobiom kann frühzeitig Aufschluss über das Risiko einer späteren Demenz-Erkrankung geben | EQS-News: SYNLAB AG
/ Schlagwort(e): Kooperation/Studienergebnisse
Studienergebnisse zeigen: Darmmikrobiom kann frühzeitig Aufschluss über das Risiko einer späteren Demenz-Erkrankung... ► Artikel lesen | |
NUGEN MEDICAL DEVICES | 0,033 | -4,07 % | Beaking News: Vive la InsuJet - mit der Krankenkasse zum Erfolg? | ||
ATOSSA THERAPEUTICS | 0,707 | +0,57 % | RedChip Companies, Inc.: Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | ORLANDO, FL / ACCESS Newswire / August 1, 2025 / RedChip Companies will air interviews with Calidi Biotherapeutics, Inc. (NYSE American:CLDI) and Atossa Therapeutics, Inc. (Nasdaq:ATOS) on the RedChip... ► Artikel lesen | |
PING AN HEALTHCARE | 1,320 | +0,57 % | PA GOODDOCTOR (01833): NOTICE OF BOARD MEETING | ||
EVOFEM BIOSCIENCES | - | - | Windtree Therapeutics: Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem's Hormone-Free, On-Demand Prescription Contraceptive Gel | Windtree rapidly advancing lower cost PHEXXI manufacturing under March 2025 sourcing agreement Contract inked with outside U.S manufacturer to cut PHEXXI manufacturing costs by over 50% by end of... ► Artikel lesen | |
UNIDOC HEALTH | 0,140 | -3,97 % | UniDoc Health Corp. kündigt Teilnahme an der Ukraine Recovery Conference (URC2025) an | - UniDoc wird auf der internationalen Veranstaltung in Rom (Italien) seine laufenden humanitären und innovativen Bemühungen im Gesundheitswesen
präsentieren
VANCOUVER,... ► Artikel lesen | |
SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results | Revenues increased 9% in Q4 2025 compared to Q4 2024, and 12% in FY 2025 compared to FY 2024Net loss improved 27% in Q4 2025 compared to Q4 2024, and 29% in FY 2025 compared to FY 2024EBITDA loss improved... ► Artikel lesen | |
MOUNTAIN VALLEY MD | 0,011 | -22,97 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
CO-DIAGNOSTICS | 0,232 | +8,41 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
CYTOSORBENTS | 0,750 | -1,83 % | Cytosorbents Corp: CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR | PRINCETON, N.J., July 2, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions... ► Artikel lesen | |
EMPOWER CLINICS | - | - | Empower Clinics Inc. - REVOKED, Commission order revoking Exchange Act registration [Section 12(j)] | ||
QUIDELORTHO | 19,200 | -3,03 % | QuidelOrtho Corporation: QuidelOrtho Strengthens Leadership Team With Appointments of Senior Vice Presidents for Global Quality and Clinical & Regulatory Affairs | New executives bring deep expertise to elevate quality and accelerate innovation across global operations SAN DIEGO, July 7, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL)... ► Artikel lesen | |
VERU | 0,410 | -2,98 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen |